Cargando…

Tuberculosis Antigen-Specific T-Cell Responses During the First 6 Months of Antiretroviral Treatment

The reconstitution of Mycobacterium tuberculosis antigen-specific CD4 T cells in a cohort of HIV-infected persons starting antiretroviral treatment (ART) in a high tuberculosis endemic area is described. Restoration of the antigen-specific CD4 T-cell subsets mirrored the overall CD4 T-cell compartme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riou, Catherine, Jhilmeet, Nishtha, Rangaka, Molebogeng X, Wilkinson, Robert J, Wilkinson, Katalin A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910879/ https://www.ncbi.nlm.nih.gov/pubmed/31419285 http://dx.doi.org/10.1093/infdis/jiz417

Ejemplares similares

Role of the Interleukin 10 Family of Cytokines in Patients With Immune Reconstitution Inflammatory Syndrome Associated With HIV Infection and Tuberculosis
por: Tadokera, Rebecca, et al.
Publicado: (2013)

The effect of antiretroviral treatment on selected genes in whole blood from HIV-infected adults sensitised by Mycobacterium tuberculosis
por: Jhilmeet, Nishtha, et al.
Publicado: (2018)

A Systematic Review on the Safety of Mycobacterium tuberculosis–Specific Antigen–Based Skin Tests for Tuberculosis Infection Compared With Tuberculin Skin Tests
por: Hamada, Yohhei, et al.
Publicado: (2023)

Antiretroviral Treatment-Induced Decrease in Immune Activation Contributes to Reduced Susceptibility to Tuberculosis in HIV-1/Mtb Co-infected Persons
por: Wilkinson, Katalin A., et al.
Publicado: (2021)

Population tailored modification of tuberculosis specific interferon-gamma release assay
por: Horvati, Kata, et al.
Publicado: (2016)

Altered Ratio of IFN-γ/IL-10 in Patients with Drug Resistant Mycobacterium tuberculosis and HIV- Tuberculosis Immune Reconstitution Inflammatory Syndrome
por: Skolimowska, Keira H., et al.
Publicado: (2012)

Invariant Natural Killer T-cell Dynamics in Human Immunodeficiency Virus–associated Tuberculosis
por: Walker, Naomi F, et al.
Publicado: (2020)

Phenotypic Profile of Mycobacterium tuberculosis-Specific CD4 T-Cell Responses in People With Advanced Human Immunodeficiency Virus Who Develop Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome
por: Moseki, Raymond M, et al.
Publicado: (2022)

Effect of HIV on the Frequency and Number of Mycobacterium tuberculosis–Specific CD4(+) T Cells in Blood and Airways During Latent M. tuberculosis Infection
por: Bunjun, Rubina, et al.
Publicado: (2017)

Plasma Biomarkers to Detect Prevalent or Predict Progressive Tuberculosis Associated With Human Immunodeficiency Virus–1
por: Lesosky, Maia, et al.
Publicado: (2019)

Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?
por: Rangaka, Molebogeng X, et al.
Publicado: (2022)

Inflammasome Activation Underlying Central Nervous System Deterioration in HIV-Associated Tuberculosis
por: Marais, Suzaan, et al.
Publicado: (2017)

Cytotoxic Mediators in Paradoxical HIV–Tuberculosis Immune Reconstitution Inflammatory Syndrome
por: Wilkinson, Katalin A., et al.
Publicado: (2015)

The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials
por: Abubakar, Ibrahim, et al.
Publicado: (2020)

Blood and Site of Disease Inflammatory Profiles Differ in Patients With Pericardial Tuberculosis and Human Immunodeficiency Virus Type 1
por: Mutavhatsindi, Hygon, et al.
Publicado: (2023)

World TB Day 2018: The Challenge of Drug Resistant Tuberculosis
por: Gupta-Wright, Ankur, et al.
Publicado: (2018)

Hemostatic Changes Associated With Increased Mortality Rates in Hospitalized Patients With HIV-Associated Tuberculosis: A Prospective Cohort Study
por: Janssen, Saskia, et al.
Publicado: (2017)

Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence
por: Rockwood, Neesha, et al.
Publicado: (2017)

Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence
por: Hamada, Yohhei, et al.
Publicado: (2021)

Cryptococcal Antigen Screening Among Antiretroviral Therapy–Experienced People With HIV With Viral Load Nonsuppression in Rural Uganda
por: Baluku, Joseph Baruch, et al.
Publicado: (2021)

Association of First-Line and Second-Line Antiretroviral Therapy Adherence
por: Ramadhani, Habib O., et al.
Publicado: (2014)

Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis
por: De Castro, Nathalie, et al.
Publicado: (2022)

Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options
por: Meloni, Seema T, et al.
Publicado: (2017)

A Glucuronoxylomannan-Associated Immune Signature, Characterized by Monocyte Deactivation and an Increased Interleukin 10 Level, Is a Predictor of Death in Cryptococcal Meningitis
por: Scriven, James E., et al.
Publicado: (2016)

The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges
por: Naidoo, Pren, et al.
Publicado: (2017)

Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy–Accessing Participants: Incidence, Clinical Course, and Outcomes( )
por: Naidoo, Kogieleum, et al.
Publicado: (2022)

Differential Pathogen-Specific Immune Reconstitution in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Children
por: Muenchhoff, Maximilian, et al.
Publicado: (2019)

Ratio of Monocytes to Lymphocytes in Peripheral Blood Identifies Adults at Risk of Incident Tuberculosis Among HIV-Infected Adults Initiating Antiretroviral Therapy
por: Naranbhai, Vivek, et al.
Publicado: (2014)

Relationship Between HIV Coinfection, Interleukin 10 Production, and Mycobacterium tuberculosis in Human Lymph Node Granulomas
por: Diedrich, Collin R., et al.
Publicado: (2016)

Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis
por: Rockwood, Neesha, et al.
Publicado: (2017)

Optimal Timing of Antiretroviral Therapy Initiation in Children and Adolescents With Human Immunodeficiency Virus-Associated Pulmonary Tuberculosis
por: Kay, Alexander, et al.
Publicado: (2022)

Analysis of the Phenotype of Mycobacterium tuberculosis-Specific CD4+ T Cells to Discriminate Latent from Active Tuberculosis in HIV-Uninfected and HIV-Infected Individuals
por: Riou, Catherine, et al.
Publicado: (2017)

Human Immunodeficiency Virus (HIV)–Infected CCR6(+) Rectal CD4(+) T Cells and HIV Persistence On Antiretroviral Therapy
por: Anderson, Jenny L, et al.
Publicado: (2020)

Characterization of Mycobacterium tuberculosis–Specific Th22 Cells and the Effect of Tuberculosis Disease and HIV Coinfection
por: Makatsa, Mohau S., et al.
Publicado: (2022)

Impact of Xpert MTB/RIF on Antiretroviral Therapy-Associated Tuberculosis and Mortality: A Pragmatic Randomized Controlled Trial
por: Mupfumi, L., et al.
Publicado: (2014)

The bacillary and macrophage response to hypoxia in tuberculosis and the consequences for T cell antigen recognition
por: Prosser, Gareth, et al.
Publicado: (2017)

Plasma Profiles of Inflammatory Markers Associated With Active Tuberculosis in Antiretroviral Therapy-Naive Human Immunodeficiency Virus-Positive Individuals
por: Olsson, Oskar, et al.
Publicado: (2019)

Interleukin-7 Unveils Pathogen-Specific T Cells by Enhancing Antigen-Recall Responses
por: Terrazzini, Nadia, et al.
Publicado: (2018)

The Survival Benefits of Antiretroviral Therapy in South Africa
por: April, Michael D., et al.
Publicado: (2014)

Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of Life
por: Maswabi, Kenneth, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rvgf208sah3m3n6jsrahbun63j